| Authors: |
Barbosa RP; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France., Bastos P; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France., Béreau M; Département de Neurologie, CHU de Besançon, 25000, Besançon, France; Université de Franche-Comté, LINC Laboratoire de Recherches Intégratives en Neurosciences et Psychologie Cognitive, 25000, Besançon, France., Rolland AS; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, NS-PARK/FCRIN Network, F-59000, Lille, France., Rascol O; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France., Brefel-Courbon C; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France., Ory-Magne F; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France., de Barros A; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France., Moreau C; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, NS-PARK/FCRIN Network, F-59000, Lille, France., Hainque E; Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, and Institut du Cerveau et de la Moëlle épinière, NS-PARK/FCRIN Network, F-75013, Paris, France., Rouaud T; Department of Neurology, Nantes University Hospital, NS-PARK/FCRIN Network, Cedex, 44093, Nantes, France., Marques A; Université Clermont Auvergne, EA7280, Clermont-Ferrand University Hospital, Neurology Department, NS-PARK/FCRIN Network, 63000, Clermont-Ferrand, France., Eusebio A; Aix Marseille Université, AP-HM, Hôpital de La Timone, Service de Neurologie et Pathologie du Mouvement, and UMR CNRS, France., Colin O; Service de Neurologie, Centre Hospitalier de Brive-la-Gaillarde, France; Centre Expert Parkinson, CHU de Limoges, France., Drapier S; Behavior and Basal Ganglia' Research Unit (EA 4712), University of Rennes 1, Rennes, France; Department of Neurology, Rennes University Hospital, NS-PARK/FCRIN Network, Cedex, 35033, Rennes, France; Department of Neurology, Rennes University Hospital, CIC INSERM 1414, NS-PARK/FCRIN Network, Cedex, 35033, Rennes, France., Guehl D; CHU de Bordeaux, Centre Expert Parkinson, Institut des maladies Neuro-dégénératives, F-33000, Bordeaux, France., Maltete D; Department of Neurology, Rouen University Hospital and University of Rouen, France; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, NS-PARK/FCRIN Network, Mont-Saint-Aignan, France., Tranchant C; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, NS-PARK/FCRIN Network, Strasbourg, France., Giordana C; Service Universitaire de Psychiatrie, Hôpital Pasteur 1, CHU de Nice, Nice, France; Neurology Department, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France., Tir M; Department of Neurology, Department of Neurosurgery, Expert Centre for Parkinson's disease, Amiens University Hospital, EA 4559, Laboratoire de Neurosciences Fonctionnelles et Pathologie (LNFP), Université de Picardie Jules Verne, University of Picardy Jules Verne (UPJV), NS-PARK/FCRIN Network, France., Thobois S; Univ Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux, CNRS, Institut des Sciences Cognitives, UMR, 5229, Bron, France; Centre Expert Parkinson, Hôpital Neurologique 'Pierre Wertheimer,', Hospices Civils de Lyon, NS-PARK/FCRIN Network, Lyon, France., Hopes L; Neurology Department, Nancy University Hospital, 54000, Nancy, France., Brandel JP; Hôpital Fondation Ophtalmologique A de Rothschild, Unité James Parkisnon, NS-PARK/FCRIN Network, F-75019, Paris, France., Jarraya B; Pôle Neurosciences, Foch Hospital, Suresnes, France; Université de Versailles Paris-Saclay, INSERM U992, CEA Neurospin, France., Corvol JC; Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, and Institut du Cerveau et de la Moëlle épinière, NS-PARK/FCRIN Network, F-75013, Paris, France., Devos D; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, NS-PARK/FCRIN Network, F-59000, Lille, France., Fabbri M; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France. Electronic address: margheritafabbrimd@gmail.com. |
